CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 14, 2019-- Ra Pharmaceuticals, Inc. (Nasdaq:RARX) today announced that senior management will present at the following upcoming investor conferences:

• The UBS Global Healthcare Conference 2019 on Tuesday, May 21, 2019 at 9:00 a.m. E.T. The conference will be held at the Grand Hyatt New York in New York, NY.
• The 2019 RBC Capital Markets Global Healthcare Conference onWednesday, May 22, 2019 at 11:30 a.m. E.T. The conference will be held at the InterContinental New York Barclay in New York, NY.

The presentations will be webcast live and can be accessed by visiting the investor relations section of the Company’s website, www.rapharma.com. A replay of each presentation will be available and archived on the site for three weeks.

About Ra Pharmaceuticals

Ra Pharmaceuticals is a clinical-stage biopharmaceutical company focused on leading the field of complement biology to bring innovative and accessible therapies to patients with rare diseases. The Company discovers and develops peptides and small molecules to target key components of the complement cascade. For more information, please visit: www.rapharma.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190514005074/en/

Source: Ra Pharmaceuticals, Inc.

Investors:
Ra Pharmaceuticals
Natalie Wildenradt, 617-674-9874
nwildenradt@rapharma.com

Media:
Argot Partners
David Rosen, 212-600-1902
david.rosen@argotpartners.com